Acorah Software Products - Accounts Production 16.1.300 false true true 31 March 2023 1 April 2022 false 1 April 2023 31 March 2024 31 March 2024 10694447 Dr Mehdi Shahidi Dr Peyman Gifani Mr Matthew Gregory Richard Cleevely iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 10694447 frs-core:CurrentFinancialInstruments frs-core:WithinOneYear 2024-03-31 10694447 2023-03-31 10694447 2024-03-31 10694447 2023-04-01 2024-03-31 10694447 frs-core:CurrentFinancialInstruments 2024-03-31 10694447 frs-core:BetweenOneFiveYears 2024-03-31 10694447 frs-core:ComputerEquipment 2024-03-31 10694447 frs-core:ComputerEquipment 2023-04-01 2024-03-31 10694447 frs-core:ComputerEquipment 2023-03-31 10694447 frs-core:DevelopmentCostsCapitalisedDevelopmentExpenditure 2023-04-01 2024-03-31 10694447 frs-core:FurnitureFittings 2024-03-31 10694447 frs-core:FurnitureFittings 2023-04-01 2024-03-31 10694447 frs-core:FurnitureFittings 2023-03-31 10694447 frs-core:OtherResidualIntangibleAssets 2024-03-31 10694447 frs-core:OtherResidualIntangibleAssets 2023-04-01 2024-03-31 10694447 frs-core:OtherResidualIntangibleAssets 2023-03-31 10694447 frs-core:WithinOneYear 2024-03-31 10694447 frs-core:OtherReservesSubtotal 2024-03-31 10694447 frs-core:SharePremium 2024-03-31 10694447 frs-core:ShareCapital 2024-03-31 10694447 frs-core:RetainedEarningsAccumulatedLosses 2024-03-31 10694447 frs-bus:PrivateLimitedCompanyLtd 2023-04-01 2024-03-31 10694447 frs-bus:FilletedAccounts 2023-04-01 2024-03-31 10694447 frs-bus:SmallEntities 2023-04-01 2024-03-31 10694447 frs-bus:AuditExempt-NoAccountantsReport 2023-04-01 2024-03-31 10694447 frs-bus:SmallCompaniesRegimeForAccounts 2023-04-01 2024-03-31 10694447 frs-bus:Director1 2023-04-01 2024-03-31 10694447 frs-bus:Director2 2023-04-01 2024-03-31 10694447 frs-bus:Director3 2023-04-01 2024-03-31 10694447 frs-countries:EnglandWales 2023-04-01 2024-03-31 10694447 frs-core:CurrentFinancialInstruments frs-core:WithinOneYear 2023-03-31 10694447 2022-03-31 10694447 2023-03-31 10694447 2022-04-01 2023-03-31 10694447 frs-core:CurrentFinancialInstruments 2023-03-31 10694447 frs-core:BetweenOneFiveYears 2023-03-31 10694447 frs-core:WithinOneYear 2023-03-31 10694447 frs-core:OtherReservesSubtotal 2023-03-31 10694447 frs-core:SharePremium 2023-03-31 10694447 frs-core:ShareCapital 2023-03-31 10694447 frs-core:RetainedEarningsAccumulatedLosses 2023-03-31
Registered number: 10694447
Aivivo Ltd
Unaudited Financial Statements
For The Year Ended 31 March 2024
Max Accountants Ltd
Ketton Suite
The King Centre
Oakham
Rutland
LE15 7WD
Contents
Page
Balance Sheet 1—2
Notes to the Financial Statements 3—6
Page 1
Balance Sheet
Registered number: 10694447
2024 2023
Notes £ £ £ £
FIXED ASSETS
Intangible Assets 4 2,250 -
Tangible Assets 5 4,958 3,780
7,208 3,780
CURRENT ASSETS
Debtors 6 288,167 178,750
Cash at bank and in hand 315,437 728,683
603,604 907,433
Creditors: Amounts Falling Due Within One Year 7 (1,318,638 ) (1,292,288 )
NET CURRENT ASSETS (LIABILITIES) (715,034 ) (384,855 )
TOTAL ASSETS LESS CURRENT LIABILITIES (707,826 ) (381,075 )
NET LIABILITIES (707,826 ) (381,075 )
CAPITAL AND RESERVES
Called up share capital 9 121 121
Share premium account 464,979 464,979
Other Reserves 32,431 14,412
Profit and Loss Account (1,205,357 ) (860,587 )
SHAREHOLDERS' FUNDS (707,826) (381,075)
Page 1
Page 2
For the year ending 31 March 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The company has taken advantage of section 444(1) of the Companies Act 2006 and opted not to deliver to the registrar a copy of the company's Profit and Loss Account.
On behalf of the board
Dr Peyman Gifani
Director
26 March 2025
The notes on pages 3 to 6 form part of these financial statements.
Page 2
Page 3
Notes to the Financial Statements
1. General Information
Aivivo Ltd is a private company, limited by shares, incorporated in England & Wales, registered number 10694447 . The registered office is 25 Bioinnovation Centre, Cambridge Science Park, Milton, Cambridge, England, CB4 0FW.
2. Accounting Policies
2.1. Basis of Preparation of Financial Statements
The financial statements have been prepared under the historical cost convention and in accordance with Financial Reporting Standard 102 section 1A Small Entities "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006.
The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.
2.2. Going Concern Disclosure
The directors have not identified any material uncertainties related to events or conditions that may cast significant doubt about the company's ability to continue as a going concern. Therefore the financial statements have been prepared on a going concern basis which assumes the Company will continue in operational existence for the foreseeable future. 
The Company is involved in research and development activities and is working towards achieving a sustainable revenue generating activity. The directors have considered the basis of the financial statements and are satisfied that a combination of business growth and further investment commitments will enable the Company to meet its liabilities as they fall due.
2.3. Intangible Fixed Assets and Amortisation - Other Intangible
Other intangible assets are Trademarks and Patents. It is amortised to profit and loss account over its estimated economic life of 10 years.
2.4. Tangible Fixed Assets and Depreciation
Tangible fixed assets are measured at cost less accumulated depreciation and any accumulated impairment losses. Depreciation is provided at rates calculated to write off the cost of the fixed assets, less their estimated residual value, over their expected useful lives on the following bases:
Fixtures & Fittings Straight line, 3 years
Computer Equipment Straight line, 3 years
2.5. Cash and Cash Equivalents
Cash and cash equivalents are basic financial assets and include cash in hand and deposits held at call with banks, other short-term highly liquid investments that mature in no more than three months from the date of acquisition and are readily convertible to a known amount of cash with insignificant risk of change in value, and bank overdrafts.
2.6. Financial Instruments
The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.
Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.
Basic financial assets
Basic financial assets, which include debtors and bank balances, are measured at transaction price including transaction costs.
Classification of financial liabilities
Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.
Basic financial liabilities
Basic financial liabilities, including creditors, are recognised at transaction price including transaction costs.
Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities.
Page 3
Page 4
2.7. Taxation
Tax is recognised in profit or loss except that a charge is attributable to an item of income and expense recognised as other comphrehensive income or to an item recognised directly in equity is also recognised in other comphrehensive income or directly in equity respectively.
The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the balance sheet date in the countries where the company operates and generates income.
2.8. Pensions
The company operates a defined pension contribution scheme. Contributions are charged to the profit and loss account as they become payable in accordance with the rules of the scheme.
2.9. Convertible Debt
Compound financial instruments issued by the Company comprise convertible loan notes that can be converted to share capital at the option of the holder. The interest on the loan notes is compounding annually and as such the number of shares to be issued will vary with changes in the fair value.
Due to the varying number of shares to be issued the loan notes are treated as liabilities and not split between equity and liabilities. The liability is initially and subsequently measured at fair value, with the fair value movements recognised in the Statement of Comprehensive Income.
Transaction costs that relate to the issue of the instrument are expensed to the Statement of Comprehensive Income.
2.10. Research and Development
In the research phase of an internal project, it is not possible to demonstrate that the project will generate future economic benefits and hence all expenditure on research shall be recognised as an expense when it is incurred. Intangible assets are recognised from the development phase of a project if and only if certain specific criteria are met in order to demonstrate the asset will generate probable future economic benefits and that its cost can be reliably measured. The capitalised development costs are subsequently amortised on a straight-line basis over their useful economic lives. 
If it is not possible to distinguish between the research phase and the development phase of an internal project, the expenditure is treated as if it were all incurred in the research phase only. 
3. Average Number of Employees
Average number of employees, including directors, during the year was: 2 (2023: 3)
2 3
4. Intangible Assets
Trademarks & Patents
£
Cost
As at 1 April 2023 -
Additions 2,370
As at 31 March 2024 2,370
Amortisation
As at 1 April 2023 -
Provided during the period 120
As at 31 March 2024 120
Net Book Value
As at 31 March 2024 2,250
As at 1 April 2023 -
Page 4
Page 5
5. Tangible Assets
Fixtures & Fittings Computer Equipment Total
£ £ £
Cost
As at 1 April 2023 662 9,827 10,489
Additions - 3,749 3,749
As at 31 March 2024 662 13,576 14,238
Depreciation
As at 1 April 2023 662 6,047 6,709
Provided during the period - 2,571 2,571
As at 31 March 2024 662 8,618 9,280
Net Book Value
As at 31 March 2024 - 4,958 4,958
As at 1 April 2023 - 3,780 3,780
6. Debtors
2024 2023
£ £
Due within one year
Other debtors 47,582 4,444
Corporation tax recoverable assets 225,278 167,177
VAT 5,629 7,129
Directors' loan accounts 9,678 -
288,167 178,750
7. Creditors: Amounts Falling Due Within One Year
2024 2023
£ £
Trade creditors 24,435 10,358
Other loans 46,000 46,000
Other taxes and social security 15,541 9,069
Other creditors 1,218,087 1,217,144
Accruals and deferred income 14,575 9,550
Directors' loan accounts - 167
1,318,638 1,292,288
8. Loans
An analysis of the maturity of loans is given below:
2024 2023
£ £
Amounts falling due within one year or on demand:
Other loans 46,000 46,000
Page 5
Page 6
9. Share Capital
2024 2023
£ £
Allotted, Called up and fully paid 121 121
10. Other Commitments
The total of future minimum lease payments under non-cancellable operating leases are as following:
2024 2023
£ £
Not later than one year 34,148 -
Later than one year and not later than five years 28,909 -
63,057 -
Page 6